drugset / Trial / NCT03774576

A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RO7017773 in Healthy Participants

NCT03774576 ↗

Phase 1 Completed 14 enrolled Hoffmann-La Roche
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the effect of multiple oral doses of itraconazole on the pharmacokinetics of RO7017773 in healthy volunteers.

Timeline

Start
2018-12-17
Primary completion
2019-03-14
Completion
2019-03-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Alogabat Small molecule — —
Subject Itraconazole Small molecule — Oral

Indications

No indication recorded.